T&R Biofab Co., Ltd. (KOSDAQ:246710)
South Korea · Delayed Price · Currency is KRW 2,230.00
-45.00 (-1.98%)
Sep 21, 2026, 3:30 PM KST
T&R Biofab Market Cap
T&R Biofab has a market cap or net worth of 108.44 billion as of September 18, 2026. Its market cap has increased by 118.33% in one year.
Market Cap
108.44B
Enterprise Value
132.84B
Revenue
32.73B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,230.00
ChartMarket Cap Chart
Since November 28, 2018, T&R Biofab's market cap has increased from 101.48B to 108.44B, an increase of 6.86%. That is a compound annual growth rate of 0.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 108.44B | -39.51% |
| Dec 30, 2025 | 179.28B | 91.93% |
| Dec 30, 2024 | 93.41B | -51.40% |
| Dec 28, 2023 | 192.21B | -20.80% |
| Dec 29, 2022 | 242.68B | -53.25% |
| Dec 30, 2021 | 519.07B | 265.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bio Plus | 206.16B |
| Boditech Med | 202.75B |
| Shinhung | 133.59B |
| Dongbang Medical | 122.04B |
| Osang Healthcare Co.,Ltd | 91.60B |
| Access Bio | 81.43B |
| Ray Co., Ltd. | 72.34B |
| Sugentech | 70.56B |